SummaryQufu LeKang Medical Technology Group Co., Ltd. manufactures and sells intelligent operating-room and ICU equipment, including operating tables, surgical lights, suspension towers, hospital beds, and related products. It reports a 20,000 m² manufacturing plant and a product-focused quality management system, with precise instrument testing stated for each production process. The supplier holds ISO 9001, ISO 13485, ISO 14001, ROHS environmental protection, and CE certifications. It also reports nationwide offices, after-sales and technical-support centers, and service coverage in more than 30 countries and regions serving over 8,000 medical institutions. However, the provided information does not substantiate R&D, OEM/ODM, customization, financial strength, traceability, outsourcing, warehouse, or overseas-agent capabilities. No financial figures are included.
Supplier typeThe supplier is identified as a manufacturer and seller of intelligent operating-room and ICU professional integrated equipment. Its listed products include operating tables, surgical lights, suspension towers, maternity beds, nursing beds, sickbeds, carts, and medical counters, indicating a medical-equipment manufacturing profile.
CertificationsThe supplier explicitly reports ISO 9001 and ISO 13485 quality-system certifications, ISO 14001 environmental-management certification, ROHS environmental-protection certification, and CE certification. These certifications directly support its quality, medical-device, environmental, and product-compliance credentials.
After-Sales capabilityThe supplier reports nationwide offices, after-sales service and technical-support centers, as well as a consulting service technical team focused on product service and expert consultation. It also states that customer-end service is the final quality-assurance checkpoint, providing explicit evidence of an established after-sales support structure.
Production capacityThe supplier reports a 20,000 m² manufacturing plant, a broad product range, and precise instrument testing for each production process, with a stated 100% pass rate for factory inspections and market-supervision checks. These statements provide explicit evidence of manufacturing infrastructure and process-control capability, although production capacity, throughput, and fulfillment details are not fully documented.
Client casesThe supplier states that it has established a service network in more than 30 countries and regions and provides health services to over 8,000 medical institutions through surgical purification projects. These stated deployment figures constitute explicit evidence of broad institutional customer experience, although individual customer names and project details are not provided.